Literature DB >> 26763556

Evaluating predictors of competing risk outcomes when censoring depends on time-dependent covariates, with application to safety and efficacy of HIV treatment.

Judith J Lok1, Michael D Hughes1.   

Abstract

We propose a prediction model for the cumulative incidence functions of competing risks, based on a logit link. Because of a concern about censoring potentially depending on time-varying covariates in our motivating human immunodeficiency virus (HIV) application, we describe an approach for estimating the parameters in the prediction models using inverse probability of censoring weighting under a missingness at random assumption. We then illustrate the application of this methodology to identify predictors of the competing outcomes of virologic failure, an efficacy outcome, and treatment limiting adverse event, a safety outcome, among human immunodeficiency virus-infected patients first starting antiretroviral treatment.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  HIV/AIDS; competing risks; logit link; missing at random; personalized medicine; safety and efficacy

Mesh:

Substances:

Year:  2016        PMID: 26763556      PMCID: PMC4853244          DOI: 10.1002/sim.6852

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  16 in total

1.  Predictors and impact of patients lost to follow-up in a long-term randomized trial of immediate versus deferred antiretroviral treatment.

Authors:  J P Ioannidis; R Bassett; M D Hughes; P A Volberding; H S Sacks; J Lau
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-09-01

2.  Predictors identified for losses to follow-up among HIV-seropositive patients.

Authors:  Emilie Lanoy; Murielle Mary-Krause; Pierre Tattevin; Rosemary Dray-Spira; Claudine Duvivier; Patricia Fischer; Yolande Obadia; France Lert; Dominique Costagliola
Journal:  J Clin Epidemiol       Date:  2006-05-30       Impact factor: 6.437

3.  Structural accelerated failure time models for survival analysis in studies with time-varying treatments.

Authors:  Miguel A Hernán; Stephen R Cole; Joseph Margolick; Mardge Cohen; James M Robins
Journal:  Pharmacoepidemiol Drug Saf       Date:  2005-07       Impact factor: 2.890

4.  Factors associated with the failure of HIV-positive persons to return for scheduled medical visits.

Authors:  Claudio Arici; Diego Ripamonti; Franco Maggiolo; Marco Rizzi; Maria Grazia Finazzi; Patrizio Pezzotti; Fredy Suter
Journal:  HIV Clin Trials       Date:  2002 Jan-Feb

5.  Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.

Authors:  Roy M Gulick; Heather J Ribaudo; Cecilia M Shikuma; Christina Lalama; Bruce R Schackman; William A Meyer; Edward P Acosta; Jeffrey Schouten; Kathleen E Squires; Christopher D Pilcher; Robert L Murphy; Susan L Koletar; Margrit Carlson; Richard C Reichman; Barbara Bastow; Karin L Klingman; Daniel R Kuritzkes
Journal:  JAMA       Date:  2006-08-16       Impact factor: 56.272

6.  Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection.

Authors:  Roy M Gulick; Heather J Ribaudo; Cecilia M Shikuma; Stephanie Lustgarten; Kathleen E Squires; William A Meyer; Edward P Acosta; Bruce R Schackman; Christopher D Pilcher; Robert L Murphy; William E Maher; Mallory D Witt; Richard C Reichman; Sally Snyder; Karin L Klingman; Daniel R Kuritzkes
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

7.  Constructing inverse probability weights for marginal structural models.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2008-08-05       Impact factor: 4.897

8.  Factors associated with early study discontinuation in AACTG studies, DACS 200.

Authors:  Janet W Andersen; Robert Fass; Charles van der Horst
Journal:  Contemp Clin Trials       Date:  2007-02-27       Impact factor: 2.226

9.  Inverse probability-of-censoring weights for the correction of time-varying noncompliance in the effect of randomized highly active antiretroviral therapy on incident AIDS or death.

Authors:  Lauren E Cain; Stephen R Cole
Journal:  Stat Med       Date:  2009-05-30       Impact factor: 2.373

10.  The Multicenter AIDS Cohort Study: retention after 9 1/2 years.

Authors:  J Dudley; S Jin; D Hoover; S Metz; R Thackeray; J Chmiel
Journal:  Am J Epidemiol       Date:  1995-08-01       Impact factor: 4.897

View more
  1 in total

1.  Estimation of the cumulative incidence function under multiple dependent and independent censoring mechanisms.

Authors:  Judith J Lok; Shu Yang; Brian Sharkey; Michael D Hughes
Journal:  Lifetime Data Anal       Date:  2017-02-25       Impact factor: 1.588

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.